Inflammatix, a cutting-edge biotech company, is gearing up for the commercial launch of their revolutionary TriVerity™ Test with the recent addition of three seasoned industry experts.
Dr. Sam Ajizian Takes the Helm
Dr. Sam Ajizian, a seasoned professional in the medical field, has been appointed to oversee the medical aspects, clinical evidence development, and medical science liaisons for the TriVerity launch. His wealth of experience promises to drive the test's success in informing treatment decisions for adult patients with suspected acute infection or sepsis.
Jamie Lewis Leads the Charge
Joining the Inflammatix team is Jamie Lewis, tasked with building and managing the TriVerity commercial organization. With a track record of leading high-performing teams to success, Lewis is set to propel the test into the market spotlight.
Laura Spencer Garth Heads Legal Affairs
Laura Spencer Garth brings her extensive experience in the medical device industry and litigation to lead the legal functions at Inflammatix. Her expertise will be crucial in navigating the regulatory landscape and ensuring compliance for the TriVerity Test. The TriVerity Test, designed to be conducted on the Myrna™ Instrument, holds immense promise in transforming treatment paradigms for patients facing acute infections. Stay tuned for more updates on Inflammatix's journey towards redefining infectious disease diagnostics.